tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Technical Analysis

Compare
549 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Kiniksa Pharmaceuticals’s (KNSA) Moving Averages Convergence Divergence (MACD) indicator is 0.87, suggesting Kiniksa Pharmaceuticals is a Sell.
Kiniksa Pharmaceuticals’s (KNSA) 20-Day exponential moving average is 43.60, while Kiniksa Pharmaceuticals’s (KNSA) share price is $45.37, making it a Buy.
Kiniksa Pharmaceuticals’s (KNSA) 50-Day exponential moving average is 42.31, while Kiniksa Pharmaceuticals’s (KNSA) share price is $45.37, making it a Buy.

Kiniksa Pharmaceuticals (KNSA) Pivot Points

Feb 15, 2026, 01:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
41.64
42.57
43.64
44.57
45.64
46.57
47.64
Fibonacci
42.57
43.33
43.81
44.57
45.33
45.81
46.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kiniksa Pharmaceuticals (KNSA) Moving Averages

Feb 15, 2026, 01:41 PM
Period
Simple
Exponential
MA5
44.82Buy
44.77Buy
MA10
44.29Buy
44.32Buy
MA20
43.44Buy
43.60Buy
MA50
42.22Buy
42.31Buy
MA100
40.68Buy
40.15Buy
MA200
35.44Buy
34.99Buy
Kiniksa Pharmaceuticals’s (KNSA) 10-Day exponential moving average is 44.32, while Kiniksa Pharmaceuticals’s (KNSA) share price is $45.37, making it a Buy.
Kiniksa Pharmaceuticals’s (KNSA) 100-Day exponential moving average is 40.15, while Kiniksa Pharmaceuticals’s (KNSA) share price is $45.37, making it a Buy.
Kiniksa Pharmaceuticals’s (KNSA) stock price is $45.37 and Kiniksa Pharmaceuticals’s (KNSA) 50-day simple moving average is 42.22, creating a Buy signal.
Kiniksa Pharmaceuticals’s (KNSA) stock price is $45.37 and Kiniksa Pharmaceuticals’s (KNSA) 100-day simple moving average is 40.68, creating a Buy signal.
Kiniksa Pharmaceuticals’s (KNSA) stock price is $45.37 and Kiniksa Pharmaceuticals’s (KNSA) 200-day simple moving average is 35.44, creating a Buy signal.

Kiniksa Pharmaceuticals (KNSA) Technical Indicators

Feb 15, 2026, 01:41 PM
Name
Value
Implied Action
RSI (14)
60.83
Neutral
STOCH (9,6)
78.46
Neutral
STOCHRSI (14)
79.95
Neutral
MACD (12,26)
0.87
Sell
ADX (14)
16.67
Buy
Williams %R
-27.41
Buy
CCI (14)
118.87
Sell
ATR (14)
1.77
-
Ultimate Oscillator
61.19
Neutral
ROC
5.02
Buy
Kiniksa Pharmaceuticals’s (KNSA) Relative Strength Index (RSI) is 60.83, creating a Neutral signal.
Kiniksa Pharmaceuticals’s (KNSA) Trend Strength Indicator (ADX) is 16.67, creating a Buy signal.
Kiniksa Pharmaceuticals’s (KNSA) Commodity Channel Index (CCI) is 118.87, creating a Sell signal.
Kiniksa Pharmaceuticals’s (KNSA) Price Rate of Change (ROC) is 5.02, creating a Buy signal.

FAQ

Is KNSA a Buy, Hold, or Sell?
Based on KNSA’s technical indicators, KNSA is a Strong Buy.
    What is KNSA’s RSI (14)?
    KNSA’s RSI (14) is 60.83, which suggests KNSA is a Neutral.
      What is KNSA’s MACD?
      KNSA’s MACD is 0.87, which suggests KNSA is a Sell.
        What is KNSA’s 5-day moving average?
        KNSA’s 5-day moving average is 44.82, which suggests KNSA is a Buy.
          What is KNSA’s 20-day moving average?
          KNSA 20-day moving average is 43.44, which suggests KNSA is a Buy.
            What is KNSA’s 50-day moving average?
            KNSA’s 50-day moving average is 42.22, which suggests KNSA is a Buy.
              What is KNSA’s 200-day moving average?
              KNSA’s 200-day moving average is 35.44, which suggests KNSA is a Buy.
                What is KNSA’s Williams % R (14)?
                KNSA’s Williams % R (14) is -27.41, which suggests KNSA is a Buy.
                  What is KNSA’s CCI (14)?
                  KNSA’s CCI (14) is 118.87, which suggests KNSA is a Sell.